Six More Women Say Odey Assaulted or Harassed Them, FT Says (Bloomberg)
Six more women have approached the Financial Times with allegations of sexual assault or harassment against Crispin Odey, according to a report Friday. The women came forward after the newspaper published a June 8 investigation into the hedge fund manager over a 25-year period that included claims from 13 women of sexual harassment or assault. The new accounts expand the time line of the alleged behavior to five decades, the FT said.
How Citadel, Millennium, Point72 and Other Hedge Fund Giants Stack up as They Enter the Second Half of a Challenging Year (Business Insider)
Hedge funds have reached the halfway point in a challenging year. The industry has underperformed the market, but there are some bright spots. Ken Griffin‘s Citadel is again top of its class, up 7.15% in 2023. Millennium bested rivals in June. The first half of 2023 was not how hedge fund managers drew it up. They invested heavily in global macro hiring late last year, expecting plenty more runway in the strategy’s revival after a blockbuster 2022.
Here are Manole Capital Management’s Thoughts about Alphabet (GOOG)’s Digi Wallet (Insider Monkey)
Manole Capital Management, an investment management company, focused on covering the Financial and Technology sectors, released its second quarter 2023 investor letter. A copy of the same can be downloaded here. The letter discussed the pending debt ceiling crisis, a few macro issues like the money market and stock market, household savings, the labor environment, the Fed, inflation trends, and interest rates. The majority of the letter is focused on specific Fintech and financial issues. In addition, please check the fund’s top five holdings to know its best picks in 2023.
Friday 7/7 Insider Buying Report: TY, CNXC (Nasdaq.com)
On Thursday, Tri Continental’s, Raghavendran Sivaraman, made a $81,211 buy of TY, purchasing 3,000 shares at a cost of $27.07 a piece. Tri Continental is trading up about 0.2% on the day Friday. This purchase marks the first one filed by Sivaraman in the past year. And on Monday, Director Kathryn Hayley purchased $25,179 worth of Concentrix, purchasing 300 shares at a cost of $83.93 a piece. This buy marks the first one filed by Hayley in the past year. Concentrix is trading up about 1.6% on the day Friday. Bargain hunters can snag CNXC at a price even lower than Hayley did, with shares trading as low as $80.14 in trading on Friday — that’s 4.5% below Hayley’s purchase price.
$5M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying (Benzinga)
Black Diamond Therapeutics: The Trade: Black Diamond Therapeutics, Inc. (BDTX) 10% owner BB Biotech AG acquired a total of 1,000,000 shares an average price of $5.00. To acquire these shares, it cost around $5 million. National HealthCare: The Trade: National HealthCare Corporation (NHC) Director Richard F. Laroche Jr. acquired a total of 2,100 shares at an average price of $61.40. To acquire these shares, it cost around $128,944.
